Elsevier

The Breast

Volume 42, December 2018, Pages 74-80
The Breast

Original article
Variations in the breast reconstruction rate in France: A nationwide study of 19,466 patients based on the French medico-administrative database

https://doi.org/10.1016/j.breast.2018.07.009Get rights and content

Highlights

  • A nationwide cohort representative of the current French breast cancer population.

  • Older age is the main factor influencing BR rate.

  • Lower BR rate in older patients (>65 years) (7.5%) than in younger ones (42.1%).

  • Disparity in BR rates across hospitals, especially for older patients.

  • BR rate heterogeneity and unequal access to high-quality procedures.

Abstract

Background

Access to breast reconstruction (BR) surgery after a mastectomy remains limited, with a large degree of national and international variation despite its known psychological benefits and impact on quality of life. The aim of this study was to investigate the factors influencing breast reconstruction in France where cancer-related healthcare costs are fully reimbursed.

Methods

All primary mastectomies for breast carcinoma performed in 2012 and linked BR surgeries from 2012 to December 2015 were extracted from the French medico-administrative database. A three-level logistic regression analysis was performed to model the probability of breast reconstruction according to patient, hospital and administrative region characteristics.

Results

Among the 19,466 women who had a mastectomy in 2012, 5328 (27.4%) had breast reconstruction. Multivariate analysis showed that the BR rate was lower in patients living in an area with an unfavourable socioeconomic level (p < .001), in low volume hospitals (p < .001), and in public hospitals (18.6%) compared to private hospitals (25.9%), university hospitals (29.8%), and cancer centres (35.0%) (p < .001). BR rate was significantly lower in patients older than 65 compared to those younger (7.5% versus 42.1%, p < .001). The impact of age was even greater in public hospitals than in other centres (interaction test, p = .001). We also observed significant heterogeneity in the BR rate across regions, which could be partially explained by differences in the plastic surgeon density.

Conclusions

Breast reconstruction rate heterogeneity could be attributed to women choice. However, our study suggests that unequal access to high-quality procedures also plays a role, particularly for older breast cancer women.

Introduction

Breast cancer is the most frequent cancer in women in Europe, with 464,000 new cases each year and 54,062 new cases in France in 2015 [1,2]. With improved treatment options resulting in a 10-year survival rate of 76%, it is essential to pay particular attention to the patient's quality of life [1]. Breast conserving surgery is performed as often as possible however, mastectomy is still needed in approximately 30% of the women treated for breast cancer [3]. For these patients, the benefit of breast reconstruction (BR) on quality of life has been widely reported due to improved physical, psychosocial and sexual well-being [[4], [5], [6]].

A review of the international literature showed significant variation in BR rates, which ranged from 4.9% to 81.2%, depending on the patient and tumour characteristics, surgeon/hospital and on psychological factors including patient choice. Among these considerations, age appears to be an important factor that influences BR rates [7]. In France, although the cost of BR is covered by national social insurance and is recommended by public health authorities, the proportion of women who opt for BR remains low (approximately 20% before 2012) [8].

The goal of this study was to investigate factors that influence BR in France in recent years by examining patient characteristics, especially patient age, as well as hospital features, regional medical access, and the interactions between these factors.

Section snippets

Patients

We used the French hospital stay database (Programme de Médicalisation des Systèmes d'Information, PMSI, secured access https://acces-securise.atih.sante.fr/vpn/index.html) to identify the population of women who underwent a mastectomy for breast cancer (BC) in 2012 and to identify whether or not these patients had BR. PMSI is a comprehensive medico-administrative database that routinely collects inpatient care data from all French hospitals. Information includes demographic data, place of

Description of the data

Of the 19,612 women who had a mastectomy due to BC in France in 2012, 19,466 were included in the current study, whereas 146 were excluded due to missing data for the FDep (0.7%). The median age in the study population was 62 years (interquartile range, 50–73; extremes, 17–101). Women aged 65 or over represented 42.7% of the study population (N = 8307). Overall, 5328 (27.4%) of the 19,466 women included in the study had BR: 13.7% (N = 2658) immediate BR and 13.7% (N = 2670) delayed BR.

Impact of age on the breast reconstruction rate

The BR

Discussion

We observed a significantly lower BR rate for older women operated in public hospitals than for younger women in a French nationwide cohort of nearly 20,000 women. Socioeconomic factors, regional heterogeneity and variation in the density of plastic surgeons also significantly influenced the BR rate.

The strength of our comprehensive study is the large number of patients from a nationwide cohort with complete data for analysis, which is representative of the current French breast cancer

Acknowledgements

The authors thank Malgorzata Cucchi for technical support and Nicolas Penel for helpful advice in publishing this manuscript.

References (23)

  • K. Flitcroft et al.

    Women's expectations of breast reconstruction following mastectomy for breast cancer: a systematic review

    Support Care Cancer Off J Multinatl Assoc Support Care Cancer

    (2017 Aug)
  • Cited by (17)

    • Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort

      2022, Clinical Breast Cancer
      Citation Excerpt :

      Additional studies need to be carried out to analyze the possibility of benchmarking, the impact of case mixes on results,20 and to analyze the differences observed on a regional level or within hospital. Are these differences caused by bias in the administrative data registry, the volume of hospital activity,27 additional procedures or treatments, or patient characteristics31, etc.? Finally, it is important to compare these results with the challenges, especially because some QIs do not reach their target: delays in access to treatment, and delays between the adjuvant treatments have an impact on recurrences and survival (Supplemental file).

    • Impact of the COVID -19 pandemic on the organisation of breast reconstruction in France

      2021, Journal of Plastic, Reconstructive and Aesthetic Surgery
    • New surgery

      2019, Presse Medicale
    View all citing articles on Scopus
    View full text